mFOFIRINOX
Showing 1 - 1 of 1
Borderline Resectable Pancreatic Cancer Trial in Pittsburgh (gemcitabine/nab-paclitaxel, mFOLFIRINOX)
Terminated
- Borderline Resectable Pancreatic Cancer
-
Pittsburgh, PennsylvaniaHillman Cancer Center
Jun 30, 2018